BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21138243)

  • 1. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption.
    Yuan H; Lu LJ; Du YZ; Hu FQ
    Mol Pharm; 2011 Feb; 8(1):225-38. PubMed ID: 21138243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
    Hu FQ; Wu XL; Du YZ; You J; Yuan H
    Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
    Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
    Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and characterization of stearic acid-grafted chitosan oligosaccharide polymeric micelles].
    Ye YQ; Hu FQ; Yuan H
    Yao Xue Xue Bao; 2004 Jun; 39(6):467-71. PubMed ID: 15491108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies.
    Hu FQ; Zhao MD; Yuan H; You J; Du YZ; Zeng S
    Int J Pharm; 2006 Jun; 315(1-2):158-66. PubMed ID: 16632285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system.
    Xie YT; Du YZ; Yuan H; Hu FQ
    Int J Nanomedicine; 2012; 7():3235-44. PubMed ID: 22802685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system.
    Li Q; Du YZ; Yuan H; Zhang XG; Miao J; Cui FD; Hu FQ
    Eur J Pharm Sci; 2010 Nov; 41(3-4):498-507. PubMed ID: 20728535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation.
    Du YZ; Lu P; Zhou JP; Yuan H; Hu FQ
    Int J Pharm; 2010 May; 391(1-2):260-6. PubMed ID: 20170716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin.
    Xu YY; Du YZ; Yuan H; Liu LN; Niu YP; Hu FQ
    J Drug Target; 2011 Jun; 19(5):344-53. PubMed ID: 20854014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles.
    Chen Q; Sun Y; Wang J; Yan G; Cui Z; Yin H; Wei H
    Artif Cells Nanomed Biotechnol; 2015; 43(4):217-23. PubMed ID: 24093764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
    Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
    Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy.
    Hu FQ; Meng P; Dai YQ; Du YZ; You J; Wei XH; Yuan H
    Eur J Pharm Biopharm; 2008 Nov; 70(3):749-57. PubMed ID: 18620050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
    Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY
    J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
    Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
    Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
    Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
    Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells.
    Du YZ; Wang L; Yuan H; Hu FQ
    Int J Biol Macromol; 2011 Jan; 48(1):215-22. PubMed ID: 21093477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel.
    Hu FQ; Ren GF; Yuan H; Du YZ; Zeng S
    Colloids Surf B Biointerfaces; 2006 Jul; 50(2):97-103. PubMed ID: 16759840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
    Mo R; Jin X; Li N; Ju C; Sun M; Zhang C; Ping Q
    Biomaterials; 2011 Jul; 32(20):4609-20. PubMed ID: 21440934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin.
    Huang X; Huang X; Jiang XH; Hu FQ; Du YZ; Zhu QF; Jin CS
    J Microencapsul; 2012; 29(1):1-8. PubMed ID: 22229874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.